Market Pulse
Daily · Oct 12, 2026 · data.go.kr + ECOS
KOSPI
6,384.24
-241.69 (-3.65%)
KOSDAQ
849.19
-43.08 (-4.83%)
KOSPI 200
1,004.92
-39.60 (-3.79%)
USD/KRW
1,335.10
326030KOSPI·Aug 27, 2026
Two concerns addressed; focus now turns to RISE3 data
Mirae Asset Securities published a company analysis report on SK biopharmaceuticals Co., Ltd. (326030) titled "Two concerns addressed; focus now turns to RISE3 data".
Summary
Covers SK biopharmaceuticals Co., Ltd. (326030).
Covered stock
More on 326030
Solid earnings; adding a second product could unlock further upsideMirae Asset Securities · Aug 07, 2026Initiating Coverage: Xcopri’s Run; Securing New Growth Engines is NextKB Securities · May 27, 2026Strong 1Q26 earnings outlook vs. full-year cost pressuresMirae Asset Securities · Feb 09, 2026Strong 2Q25 results ease concernsMirae Asset Securities · Aug 06, 2025Concerns are overblownMirae Asset Securities · May 13, 2025Leading the wayMirae Asset Securities · Feb 07, 2025